Integral Health Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $2.55 Million - $3.75 Million	-127,427 Reduced 71.82%	50,000 $1.05 Million
Q2 2022 Aug 03, 2022	BUY	$18.42 - $27.5 $689,405 - $1.03 Million	37,427 Added 26.73%	177,427 $3.45 Million
Q1 2022 May 12, 2022	BUY	$15.5 - $23.93 $620,000 - $957,200	40,000 Added 40.0%	140,000 $3.08 Million
Q4 2021 Feb 02, 2022	BUY	$13.05 - $19.35 $1.31 Million - $1.94 Million	100,000 New	100,000 $1.6 Million

197

54.3M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.